INNOVATION BIOTECH
Innovative treatments for exocrine pancreatic insufficiency to restore digestive absorption function.
Eneapharm designs a breakthrough formulation technology capable of overcoming the efficacy limitations of current treatments and fully restoring digestive absorption function.
Learn moreINNOVATION BIOTECH
Innovative treatments for exocrine pancreatic insufficiency to restore digestive absorption function.
Eneapharm designs a breakthrough formulation technology capable of overcoming the efficacy limitations of current treatments and fully restoring digestive absorption function.
Learn more
Eneapharm a pioneering bioPharmaceutical company specializing in pancreatic insufficiency, gastrointestinal and orphan healthcare.
Eneapharm is developing an advanced drug delivery system designed to overcome the limited efficacy of existing therapeutic formulations, enabling targeted enzymatic release and effective restoration of digestive absorption function.
Well-being of patients
Improve the quality of patient care and life by developing more effective treatments, delivering stronger clinical benefits, free of side effects, well tolerated with decrease of pain.
Support patients in reintegrating into social life.
This dual approach enables patients to thrive, not just survive, by enjoying improved physical health and reduced treatment burdens.
Innovation
Develop innovative formulations to facilitate the delivery of the active ingredient at the right time.
Decrease the number of daily doses.
Improve the compliance.
Time to market
Deliver, within short timelines, new therapeutic options based on well-established active ingredients that have historically been under-optimized.
For children and adults
Adapt the treatment to each age: in liquid formulation for children or capsule for older.
